New “Once a Week” Drug | More Effective than Ozempic for Weight Loss (Mounjaro)

Another diabetes drug, this time from the UK, is being heralded as a wonder drug if prescribed off label, that could be the answer to weight loss.
I hope you enjoy my content and find it interesting or informative, if so, please consider supporting the channel by using one of the affiliate links below:
* Buy me a Kofi: https://ko-fi.com/mynmnexperiment
* Patreon: https://bit.ly/3hhfjl5
* SubscribeStar: https://bit.ly/3psYo23

Renue by Science 10% Discount Code: MYNMN (https://renuebyscience.com/?rfsn=5692699.331801&coupon-code=MYNMN)

Renue by Science 15% Subscription Service Discount Code: MYNMNSUB

ProHealth 15% Discount Code: MYNMN (https://www.prohealth.com/)

DoNotAge 10% Discount Code: MYNMN (https://bit.ly/2VBDgNt)

Youth & Earth 15% Discount Code: MYNMN (https://youthandearth.com?sca_ref=3766764.knrWl4O3cB)

Please note that the links above are affiliate links, which means that if you use the code, I will receive a small commission, and if you do, may I say many thanks I advance for your support.

My Current Anti-Aging Protocol:
• 1.5 grams of NMN (https://bit.ly/3c2Fxt8)
• 1.5 grams of Trans-resveratrol (Tue, Thu & Sat) (https://bit.ly/3yxeqy2)
• 500mg Metformin
• 1.5 grams of TMG (https://bit.ly/3oe1Ted)
• 5,000 IU (International Units) of vitamin D3 (https://bit.ly/3P32hYH)
• 120 mcg (micrograms) of vitamin K2 (Mk 7) (https://bit.ly/3PhkBgn)
• 250mg Magnesium (L-Threonate) (https://bit.ly/3O4pZ5o)
• 200mg high molecular weight hyaluronic acid (https://bit.ly/3P0Z4c2)
• 2,400mg of Fisetin, on the 1st, 2nd & 3rd of each month (https://bit.ly/3P2rSB0)
• 2,400mg of Quercetin, on the 1st, 2nd & 3rd of each month (https://bit.ly/3IzulAy)
• Quercetin & Fisetin Periodic Dosing (https://bit.ly/3mw1IgN)
• 81mg of aspirin (https://bit.ly/3uFjtem)
• 800mg SIRT6 Activator (https://bit.ly/3MyfA4J)
• 600mg DIM (https://bit.ly/3ZX9NsG)
• 800mg GlyNAC (https://shorturl.ac/7b75r)

Links:
https://www.sciencealert.com/diabetes
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020673/
https://www.nejm.org/doi/full/10.1056/NEJMoa2107519
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02188-7/fulltext
https://www.nature.com/articles/s42255-019-0146-4_
https://shorturl.ac/7byvv
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758543/
https://www.ema.europa.eu/en/medicines/human/EPAR/mounjaro
https://shorturl.ac/7byw0
https://www.nice.org.uk/guidance/indevelopment/gid-ta10835
https://theconversation.com/ozempic-shortages-in-the-uk-may-last-until-2024-heres-why-208819
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632188/
https://onlinelibrary.wiley.com/doi/full/10.1002/oby.21107
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)33102-1/fulltext
https://shorturl.ac/7byvw
https://shorturl.ac/7byvy
https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
https://shorturl.ac/7byvz
https://www.nice.org.uk/guidance/gid-ta10835/documents/674
https://www.diabetes.org.uk/about_us/news/mounjaro-approved-nice-treating-type-2-diabetes
https://www.annualreviews.org/doi/abs/10.1146/annurev-nutr-062320-113625

This new drug that was developed to treat type 2 diabetes has been approved for use in the UK. Tirzepatide (to be sold under the brand name Mounjaro) could be available for prescription by early 2024, that all being subject to its availability. Mounjaro is an injectable treatment that helps the body to both control blood glucose (that’s sugars) after meals and also to regulate appetite. Research into the drug has shown it's more effective in controlling blood sugar and leads to greater weight loss when it is compared with the type 2 diabetes drugs currently available for prescription. Tirzepatide is derived from a protein with a similar structure to the hormone GIP (glucose-dependent insulinotropic peptide), which stimulates the release of insulin. But what's unique about tirzepatide is that it binds to the receptors of another hormone called GLP-1 (glucagon-like peptide 1), which also releases insulin. This makes tirzepatide the first "dual-hormone agonist" to be approved for treating type 2 diabetes. A “dual-hormone agonist” is a drug which binds to a hormone's receptor and then activates it). Semaglutide, which is sold under the brand name Ozempic, only targets GLP-1. So, how does this new drug work, how does it differ to other diabetes drugs? The hormones GLP-1 and GIP are produced by specialized cells in our large and small intestines, which release them in response to rising levels of blood glucose after a meal. Ozempic, Mounjaro, Semaglutide
FAIR-USE COPYRIGHT DISCLAIMER
Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, commenting, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational, or personal use tips the balance in favor of fair use.
#Ozempic #Mounjaro #Semaglutide